Ustekinumab
Links shared publicly online about this topic
FDA Approves Stelara (ustekinumab) to Treat Psoriasis
drugs.com — “Stelara (ustekinumab) is used to treat plaque psoriasis. Includes Stelara side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 25, 2009 at 10:34 pm By:
FDA Approves Stelara (ustekinumab) to Treat Psoriasis - http://bit.ly/nK5CX
ingentaconnect Ustekinumab: Pustular psoriasis: case report
ingentaconnect.com — “ingentaconnect Ustekinumab: Pustular psoriasis: case report” View full resource at ingentaconnect.com
Most Recently Shared on March 30, 2011 at 5:19 am By:
Ustekinumab: Pustular psoriasis: case report: (Source: Reactions) http://bit.ly/elpd7r
IngentaConnect Ustekinumab proves positive for psoriasis
ingentaconnect.com — “IngentaConnect Ustekinumab proves positive for psoriasis” View full resource at ingentaconnect.com
Most Recently Shared on June 13, 2010 at 7:18 pm By:
Ustekinumab proves positive for psoriasis: (Source: PharmacoEconomics and Outcomes News)MedWorm Message: Register ... http://bit.ly/aPlFSr
Experimental Psoriasis Drug Ustekinumab Trumps Enbrel in 3-Month Trial
webmd.com — “An experimental drug called ustekinumab shows better treatment results than an established drug, Enbrel, for treating moderate to severe plaque psoriasis in a new trial.” View full resource at webmd.com
Most Recently Shared on September 19, 2008 at 4:28 pm By:
WebMD Health News Experimental Psoriasis Drug Takes on Enbrel: An experimental drug c.. http://tinyurl.com/463afb
InfoViewer: Ustekinumab Bests Etanercept in 12-Week Study
inews.idsk.com — “InfoViewer: Ustekinumab Bests Etanercept in 12-Week Study” View full resource at inews.idsk.com
Most Recently Shared on January 13, 2010 at 11:35 pm By:
Skin & Allergy News Health News
Ustekinumab Bests Etanercept in 12-Week Study: http://bit.ly/63r2Zw
ingentaconnect New Interleukin-23 Pathway Inhibitors in Dermatology: Ustekinumab...
ingentaconnect.com — “ingentaconnect New Interleukin-23 Pathway Inhibitors in Dermatology: Ustekinumab...” View full resource at ingentaconnect.com
Most Recently Shared on February 27, 2011 at 10:42 pm By:
New Interleukin-23 Pathway Inhibitors in Dermatology: Ustekinumab, Briakinumab, and Secukinumab: (Source: Americ... http://bit.ly/gN6Zv7
Favorable 3-Year Safety Update For Ustekinumab In Psoriasis : Internal Medicine News
internalmedicinenews.com — “Favorable 3-Year Safety Update For Ustekinumab In Psoriasis : Internal Medicine News” View full resource at internalmedicinenews.com
Most Recently Shared on November 12, 2010 at 10:18 pm By:
Bob Finn - Medical News Net Health News
Ustekinumab (Stelara) for psoriasis has favorable safety rating over 3 years, Bruce Jancin reports http://bit.ly/cH96V1
IngentaConnect Ustekinumab remedies anxiety, depression in psoriasis
ingentaconnect.com — “IngentaConnect Ustekinumab remedies anxiety, depression in psoriasis” View full resource at ingentaconnect.com
Most Recently Shared on July 25, 2010 at 12:34 pm By:
Depression Wisdom Active Health Library and OW Health
Ustekinumab remedies anxiety, depression in psoriasis: (Source: PharmacoEconomics and Outcomes News)MedWorm Messag... http://bit.ly/c93nAU
Ustekinumab a Strong Option for Moderate to Severe Psoriasis - QualityPoint Technologies
qualitypointtech.net — “The interleukin-12/23 monoclonal antibody ustekinumab is proving to be a safe and effective treatment option for psoriasis. The number needed to treat was roughly 1 in a single study. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 9, 2011 at 12:46 am By:
Ustekinumab a Strong Option for Moderate to Severe Psoriasis: The interleukin-12/23 monoclonal antibody ustekinuma... http://bit.ly/qvZBk0
Symposier - Jury Still Out on Cardiovascular Risk of Ustekinumab for Psoriasis
symposier.com — “Uploaded and shared in Youtube by: ElsGlobalMedicalNews — Researcher explains the latest findings and studies” View full resource at symposier.com
Most Recently Shared on June 3, 2011 at 3:33 pm By:
Symposier Cardiology Cardiology and Health Business
Jury Still Out on Cardiovascular Risk of Ustekinumab for Psoriasis. http://bit.ly/h9aHyS
Skin and Allergy News: Ustekinumab Enhances Sexual Function for Psoriasis Patients
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic diso” View full resource at skinandallergynews.com
Most Recently Shared on March 15, 2010 at 2:27 pm By:
Skin & Allergy News Health News
Ustekinumab Enhances Sexual Function for Psoriasis Patients: http://bit.ly/bAWa2i
Briakinumab, Ustekinumab Trials Point to Future Psoriasis Treatment : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on December 16, 2010 at 3:12 pm By:
Skin & Allergy News Health News
Briakinumab, ustekinumab trials may open up new avenues of treatment for severe psoriasis:Diana Mahoney reports: http://bit.ly/hZ9WFm
Ustekinumab Re-treatment Delivers Excellent Results : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on November 28, 2011 at 7:58 pm By:
Skin & Allergy News Health News
85% of psoriasis pts re-treated w/ustekinumab after earlier successful course will experience great response in round 2 http://t.co/E9grh9sT
Clinical Cases and Images: CasesBlog: Stelara (ustekinumab) and Remicade (infliximab) are effective if Enbrel (etanercept) stops working in psoriasis
casesblog.blogspot.com — “Health News Updated Daily by an Assistant Professor at University of Chicago, Internist and Allergist” View full resource at casesblog.blogspot.com
Most Recently Shared on October 29, 2010 at 2:33 am By:
Richard L.Trader,Sr Health Executive, Physician Assistant, and Therapist
Stelara (ustekinumab) and Remicade (infliximab) are effective if Enbrel (etanercept) stops working in psoriasis: A... http://bit.ly/cUPSQZ
MedWire News - Psoriasis - Ustekinumab improves depression, anxiety in psoriasis patients
medwire-news.md — “MedWire News Ustekinumab improves symptoms of anxiety, depression, and skin-related quality of life in patients with psoriasis, US study findings show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on May 29, 2010 at 8:28 pm By:
Depression Wisdom Active Health Library and OW Health
Ustekinumab improves depression, anxiety in psoriasis patients: Ustekinumab improves symptoms of anxiety, depressi... http://bit.ly/bKFv23
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Psoriasis OW
Organizing psoriasis resources shared by health experts, advocates, and organizations into WisdomCards.
-
Psoriasis OW
Organizing psoriasis resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
